Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bismuth-containing quadruple therapy with vonoprazan vs esomeprazole for Helicobacter pylori infection has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Esomeprazole (Esomeprazole)
• TAK-438 (vonoprazan)
• Vonoprazan (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Helicobacter Pylori | Phase 3 | Status: COMPLETED | Results posted: 2023-09-07